Comparisons
RTM Market Positioning & Target Board
Comprehensive Competitive Benchmark: Carroself vs. Top 10 RTM Solution Providers
1. Clinic & Patient Cost
$0 CapEx & $45 Refundable Deposit vs $100s Hardware
2. Patient Ease of Use
Mechanical Simplicity vs Battery & Tech Complexity
3. EMR & Clinical Management
Automated Rule-of-16 Logs & CPT Billing Reports
4. Clinic Net Profit Margin
~$71/mo Net Profit per Patient (~70% Margin)
Carroself Ltd.
Market Leader (Bullseye Center)
● Clinic & Patient Cost:
98 / 100
● Patient Ease of Use:
92 / 100
● Clinical & EMR Management:
94 / 100
● Clinic Net Profit:
100 / 100
Overall Index Score:
96.0
Carroself leads the target board with $0 CapEx for clinics, a fully refundable $45 deposit for patients, mechanical reliability, and maximum net profit per patient under Medicare CPT RTM billing codes.
| Company Name | 1. Clinic/Patient Cost | 2. Patient Ease | 3. EMR & Reports | 4. Clinic Profit | Overall Index Score |
|---|
1. Target Board Structure & Scoring Logic
The target board represents competitive positioning across the US Remote Therapeutic Monitoring (RTM) ecosystem. Scores range from 20 (outer edge - low performance) to 100 (center bullseye - optimal market position).
- Bullseye Ring (80 to 100): Optimal commercial viability, $0 clinic capital outlay, maximum profitability, and zero technical friction. Carroself is the sole provider maintaining all 4 metric points inside this ring.
- Rings 40 to 80: Mid-tier competitors burdened by expensive hardware, cellular SIM subscriptions, or complex setup requirements.
- Ring 20 (Outer Boundary): Heavy institutional hardware providers with prohibitive upfront costs ($300-$500+) that erode clinic profit margins.
2. Detailed Explanation of the 4 Category Arrows
- Green Arrow (Clinic & Patient Cost): Measures upfront financial entry barriers. Carroself scores 98/100 due to $0 CapEx for clinics and a $45 fully-refundable patient deposit (covered via FSA/HSA SIGIS approval). Competitors score lower due to $100–$500 per unit hardware fees.
- Blue Arrow (Patient Ease of Use): Measures patient compliance and mechanical reliability. Carroself scores 92/100 through intuitive non-electronic mechanical design that prevents battery failures and software glitches.
- Purple Arrow (EMR & Reports Management): Evaluates clinic administrative burden. Carroself scores 94/100 via automated tracking of Medicare's Rule-of-16 day compliance threshold and direct CPT code billing export.
- Gold Arrow (Clinic Net Profitability): Evaluates financial return for the clinic. Carroself scores 100/100 because clinics retain ~$71 net profit per patient per month out of ~$105 Medicare CPT reimbursements.
3. CPT Billing Framework & Financial Breakdown
Under Medicare CPT Remote Therapeutic Monitoring (CPT 98977 + CPT 98980), clinics average ~$105/month in total reimbursements per compliant patient.
- Carroself Flat Service Fee: $34/month total ($14 advance setup + $20 settlement post-insurance reimbursement).
- Clinic Net Profit: ~$105 reimbursement - $34 Carroself fee = ~$71 Net Profit per Patient per Month (~70% Margin).
- Patient Out-of-Pocket: $0 net cost due to the $45 refundable security deposit structure.
4. Competitive Landscape Breakdown (10 Competitors)
A summary of why competing providers lag behind Carroself on the target board:
- Hero Health / Spencer Health: High unit purchase prices ($150–$500) create heavy initial negative cash flow for clinics during months 1–3.
- MedMinder / Vaica Medical: Cellular SIM requirements and ongoing hardware leases reduce net clinic profits down to $25–$40/month.
- AdhereTech / Wisepill: Bottle-based designs lack multi-dose physical separation and struggle with Medicare Rule-of-16 adherence tracking.